Overall Technical outlook

Price Summary

2026-07-01, saw APLLTD's stock open at 843.2, hit a peak of 846.0, fall to a low of 813.3, and close lower -1.68% at 829.05, with 247682 shares changing hands.
Over the past 52 weeks, the stock reached a maximum price of 1036.0 and a minimum price of 646.55.

Technicals


Aroon: Aroon's bullish trend is ongoing, with Aroon Up consistently at the 100 level. While this suggests strong upward momentum for APLLTD, it's important to analyze this trend further with other indicators to gain a comprehensive understanding of the direction.
APLLTD aroon 0841ac
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The price is currently above the upper Bollinger Band, where it has remained since its last upward move. This suggests strong bullish momentum, potentially indicating an overbought condition. Traders might interpret this as a sign of continued strength, but caution is advised as extended periods above the band could lead to a correction or a pullback in the near future.
APLLTD bbands 0841ac
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR for APLLTD maintains its bullish outlook, setting a strong support level that could underpin further gains. This suggests that the market is likely to continue its upward trajectory, with the established support providing a safety net for ongoing bullish momentum.
APLLTD psar 0841ac
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The stochastic indicator for APLLTD shows a bullish signal, with the K-line positioned above the D-line and also above the 80 mark. This suggests strong upward momentum, indicating that the market may continue to trend higher. Traders might view this as a sign of continued strength and potential buying opportunities.
APLLTD stoch 0841ac
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for APLLTD, with no strong trend emerging.
APLLTD trippleSMA 0841ac
Tripple SMA chart for Alembic Pharmaceuticals Limited


When analyzing a company, its fundamentals—such as earnings, management efficiency, and strategic initiatives—must be considered alongside technical data. The context of the industry in which the company operates also plays a key role, as market trends and competitive dynamics can significantly impact performance. By taking a comprehensive approach, combining both fundamental and technical analysis, one can gain a deeper understanding of the company's potential for growth or risk.